PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors
PMGC Holdings Inc. (Nasdaq: ELAB) has secured approximately $1.9 million in gross proceeds through a warrant inducement agreement with institutional investors. The agreement involves the exercise of Series A warrants issued on September 24, 2024, allowing investors to purchase 969,385 shares at an amended price of $2.00 per share.
As part of the transaction, PMGC will issue new unregistered warrants to purchase an additional 969,385 shares at $2.75 per share, exercisable upon shareholder approval with a five-year expiration term. The company will file a registration statement with the SEC within 30 days for the resale of shares from the new warrants. The transaction, with Univest Securities as financial advisor, is expected to close around January 28, 2025.
PMGC Holdings Inc. (Nasdaq: ELAB) ha ottenuto circa 1,9 milioni di dollari in proventi lordi attraverso un accordo di incentivazione di warrant con investitori istituzionali. L'accordo prevede l'esercizio dei warrant di Serie A emessi il 24 settembre 2024, che consentono agli investitori di acquistare 969.385 azioni a un prezzo modificato di 2,00 dollari per azione.
Come parte della transazione, PMGC emetterà nuovi warrant non registrati per acquistare ulteriori 969.385 azioni a 2,75 dollari per azione, esercitabili previa approvazione degli azionisti con un termine di scadenza di cinque anni. L'azienda presenterà una dichiarazione di registrazione alla SEC entro 30 giorni per la rivendita delle azioni derivanti dai nuovi warrant. La transazione, con Univest Securities come consulente finanziario, dovrebbe concludersi intorno al 28 gennaio 2025.
PMGC Holdings Inc. (Nasdaq: ELAB) ha asegurado aproximadamente 1,9 millones de dólares en ingresos brutos a través de un acuerdo de inducción de warrants con inversores institucionales. El acuerdo implica el ejercicio de warrants de la Serie A emitidos el 24 de septiembre de 2024, permitiendo a los inversores comprar 969,385 acciones a un precio modificado de 2,00 dólares por acción.
Como parte de la transacción, PMGC emitirá nuevos warrants no registrados para comprar 969,385 acciones adicionales a 2,75 dólares por acción, que se podrán ejercer con la aprobación de los accionistas y tendrán un plazo de expiración de cinco años. La empresa presentará una declaración de registro a la SEC dentro de los 30 días para la reventa de acciones de los nuevos warrants. Se espera que la transacción, con Univest Securities como asesor financiero, se cierre alrededor del 28 de enero de 2025.
PMGC Holdings Inc. (Nasdaq: ELAB)는 기관 투자자와의 워런트 유도 계약을 통해 약 190만 달러의 총 수익을 확보했습니다. 이 계약은 2024년 9월 24일에 발행된 A 시리즈 워런트의 행사와 관련이 있으며, 투자자들은 주당 2.00달러에 969,385주의 주식을 구매할 수 있습니다.
거래의 일환으로 PMGC는 주당 2.75달러에 추가로 969,385주를 구매할 수 있는 새로운 비등록 워런트를 발행할 예정입니다. 이는 주주 승인 후 행사 가능하며, 유효 기간은 5년입니다. 회사는 30일 이내에 새로운 워런트로부터의 주식 재판매를 위해 SEC에 등록신청서를 제출할 것입니다. Univest Securities가 재무 고문으로 참여한 이번 거래는 2025년 1월 28일경에 마무리될 것으로 예상됩니다.
PMGC Holdings Inc. (Nasdaq: ELAB) a sécurisé environ 1,9 million de dollars de produits bruts grâce à un accord d'incitation à des warrants avec des investisseurs institutionnels. L'accord implique l'exercice des warrants de Série A émis le 24 septembre 2024, permettant aux investisseurs d'acheter 969,385 actions à un prix modifié de 2,00 dollars par action.
Dans le cadre de la transaction, PMGC émettra de nouveaux warrants non enregistrés pour acheter 969,385 actions supplémentaires à 2,75 dollars par action, exerçables avec l'approbation des actionnaires et avec une échéance de cinq ans. La société soumettra une déclaration d'enregistrement à la SEC dans les 30 jours pour la revente des actions provenant des nouveaux warrants. La transaction, avec Univest Securities comme conseiller financier, devrait se clôturer autour du 28 janvier 2025.
PMGC Holdings Inc. (Nasdaq: ELAB) hat etwa 1,9 Millionen Dollar Bruttoerlöse durch einen Vereinbarung zur Aufforderung von Warrants mit institutionellen Investoren gesichert. Die Vereinbarung beinhaltet die Ausübung von Serie-A-Warrants, die am 24. September 2024 ausgegeben wurden und es den Investoren ermöglichen, 969.385 Aktien zu einem geänderten Preis von 2,00 Dollar pro Aktie zu kaufen.
Im Rahmen der Transaktion wird PMGC neue, nicht registrierte Warrants ausgeben, um weitere 969.385 Aktien zu einem Preis von 2,75 Dollar pro Aktie zu erwerben, die nach Genehmigung der Aktionäre und mit einer Laufzeit von fünf Jahren ausgeübt werden können. Das Unternehmen wird innerhalb von 30 Tagen eine Registrierungserklärung bei der SEC für den Wiederverkauf von Aktien aus den neuen Warrants einreichen. Die Transaktion, bei der Univest Securities als Finanzberater fungiert, soll voraussichtlich um den 28. Januar 2025 abgeschlossen werden.
- Secured $1.9 million in gross proceeds through warrant exercise
- Successful engagement with institutional investors indicating market confidence
- Potential dilution from additional 969,385 shares from new warrants
- New warrants priced at $2.75 represent 37.5% premium over current exercise price
Insights
The $1.9 million warrant inducement deal reveals both immediate benefits and potential concerns for PMGC Holdings. The transaction structure is particularly noteworthy - existing Series A warrant holders are incentivized to exercise at a reduced price of
The financial implications are multifaceted:
- Immediate capital injection of
$1.9M strengthens the balance sheet - The
35.5% discount to market price on the warrant exercise indicates significant pressure to raise capital - New warrants at
$2.75 create potential for additional$2.67M in future funding - Dilution impact of 969,385 new shares represents approximately
3.2% of current shares outstanding
The requirement for shareholder approval on the new warrants and the 30-day registration commitment suggest a structured approach to compliance while maintaining investor protections. However, the significant discount to market price may signal cash flow pressures or challenges in securing traditional financing. The involvement of institutional investors provides some validation, though the terms suggest they demanded favorable pricing for their participation.
NEWPORT BEACH, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (formerly Elevai Labs Inc.) (the “Company” or “PMGC”) (Nasdaq: ELAB) a diversified holding company today announced it has entered into a warrant inducement agreement with existing institutional investors for the exercise of certain outstanding Series A warrants that the Company issued on September 24, 2024. Pursuant to the warrant inducement agreement, the investors have agreed to exercise the outstanding warrants to purchase an aggregate of 969,385 shares of the Company's common stock at an amended exercise price of
The closing of the warrant inducement transactions is expected to occur on or about January 28, 2025, subject to satisfaction of customary closing conditions.
Univest Securities, LLC is acting as the exclusive financial advisor for the transaction.
In consideration for the exercise of the warrants, the Company also agreed to issue to the investors unregistered new warrants to purchase an aggregate of 969,385 shares of the Company's common stock with an exercise price of
This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About PMGC Holdings Inc.
PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. Currently, our portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. We are committed to exploring opportunities in multiple sectors to maximize growth and value. For more information, please visit https://www.pmgcholdings.com.
Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as “believes,” “expects,” “plans,” “potential,” “would” and “future” or similar expressions such as “look forward” are intended to identify forward-looking statements. Forward-looking statements are made as of the date of this press release and are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, activities of regulators and future regulations and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results. Therefore, you should not rely on any of these forward-looking statements. These and other risks are described more fully in PMGC Holdings’ filings with the United States Securities and Exchange Commission (“SEC”), including the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 29, 2024, and its other documents subsequently filed with or furnished to the SEC. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at www.sec.gov. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except to the extent required by law, the Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.
IR Contact:
IR@pmgcholdings.com
FAQ
How much did PMGC Holdings (ELAB) raise through the warrant inducement in January 2025?
What is the exercise price for PMGC's (ELAB) new warrants issued in January 2025?
How many shares are involved in PMGC's (ELAB) January 2025 warrant exercise?
When will PMGC Holdings (ELAB) file the registration statement for the new warrants?
When is the expected closing date for PMGC's (ELAB) warrant inducement transaction?
